Irina Petrache

Prof. Irina Petrache

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
VGVamsi P. Guntur
Vamsi P. Guntur
TNTravis Nemkov
Travis Nemkov
EBEsther de Boer
Esther de Boer
MMMichael P. Mohning
Michael P. Mohning
DBDavid Baraghoshi
David Baraghoshi
Angelo D'AlessandroAngelo D'Alessandro
Angelo D'Alessandro
Exercise intolerance is a major manifestation of post-acute sequelae of severe acute respiratory syndrome coronavirus infection (PASC, or “long-COVID”). Exercise intolerance in PASC is associated with higher arterial blood lactate accumulation and lower fatty acid oxidation rates during graded exercise tests to volitional exertion, suggesting altered metabolism and mitochondrial dysfunction. It remains unclear whether the profound disturbances in metabolism that have been identified in plasma from patients suffering from acute coronavirus disease 2019 (COVID-19) are also present in PASC. To bridge this gap, individuals with a history of previous acute COVID-19 infection that did not require hospitalization were enrolled at National Jewish Health (Denver, CO, USA) and were grouped into those that developed PASC (n = 29) and those that fully recovered (n = 16). Plasma samples from the two groups were analyzed via mass spectrometry-based untargeted metabolomics and compared against plasma metabolic profiles of healthy control individuals (n = 30). Observational demographic and clinical data were retrospectively abstracted from the medical record. Compared to plasma of healthy controls or individuals who recovered from COVID-19, PASC plasma exhibited significantly higher free- and carnitine-conjugated mono-, poly-, and highly unsaturated fatty acids, accompanied by markedly lower levels of mono-, di- and tricarboxylates (pyruvate, lactate, citrate, succinate, and malate), polyamines (spermine) and taurine. Plasma from individuals who fully recovered from COVID-19 exhibited an intermediary metabolic phenotype, with milder disturbances in fatty acid metabolism and higher levels of spermine and taurine. Of note, depletion of tryptophan—a hallmark of disease severity in COVID-19—is not normalized in PASC patients, despite normalization of kynurenine levels—a tryptophan metabolite that predicts mortality in hospitalized COVID-19 patients. In conclusion, PASC plasma metabolites are indicative of altered fatty acid metabolism and dysfunctional mitochondria-dependent lipid catabolism. These metabolic profiles obtained at rest are consistent with previously reported mitochondrial dysfunction during exercise, and may pave the way for therapeutic intervention focused on restoring mitochondrial fat-burning capacity.

17 August 2016 in Scientific Reports
Verified
Journal Article
Open access
KSKarina A. Serban
Karina A. Serban
SRSamin Rezania
Samin Rezania
DPDaniela N. Petrusca
Daniela N. Petrusca
CPChristophe Poirier
Christophe Poirier
DCDanting Cao
Danting Cao
IPIrina Petrache
Irina Petrache
Circulating endothelial microparticles (EMPs) are emerging as biomarkers of chronic obstructive pulmonary disease (COPD) in individuals exposed to cigarette smoke (CS), but their mechanism of release and function remain unknown. We assessed biochemical and functional characteristics of EMPs and circulating microparticles (cMPs) released by CS. CS exposure was sufficient to increase microparticle levels in plasma of humans and mice and in supernatants of primary human lung microvascular endothelial cells. CS-released EMPs contained predominantly exosomes that were significantly enriched in let-7d, miR-191; miR-126; and miR125a, microRNAs that reciprocally decreased intracellular in CS-exposed endothelium. CS-released EMPs and cMPs were ceramide-rich and required the ceramide-synthesis enzyme acid sphingomyelinase (aSMase) for their release, an enzyme which was found to exhibit significantly higher activity in plasma of COPD patients or of CS-exposed mice. The ex vivo or in vivo engulfment of EMPs or cMPs by peripheral blood monocytes-derived macrophages was associated with significant inhibition of efferocytosis. Our results indicate that CS, via aSMase, releases circulating EMPs with distinct microRNA cargo and that EMPs affect the clearance of apoptotic cells by specialized macrophages. These targetable effects may be important in the pathogenesis of diseases linked to endothelial injury and inflammation in smokers.

1 January 2022 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
EBEsther de Boer
Esther de Boer
IPIrina Petrache
Irina Petrache
NGNir M. Goldstein
Nir M. Goldstein
JOJ. Tod Olin
J. Tod Olin
RKRebecca C. Keith
Rebecca C. Keith
JSJeffrey J. Swigris
Jeffrey J. Swigris

10 February 2016 in Annual Review of Physiology
Verified
Journal Article
Closed access
IPIrina Petrache
Irina Petrache
EBEvgeny Berdyshev
Evgeny Berdyshev
Following the discovery of ceramide as the central signaling and metabolic relay among sphingolipids, studies of its involvement in lung health and pathophysiology have exponentially increased. In this review, we highlight key studies in the context of recent progress in metabolomics and translational research methodologies. Evidence points toward an important role for the ceramide/sphingosine-1-phosphate rheostat in maintaining lung cell survival, vascular barrier function, and proper host response to airway microbial infections. Sphingosine kinase 1 has emerged as an important determinant of sphingosine-1-phosphate lung levels, which, when aberrantly high, contribute to lung fibrosis, maladaptive vascular remodeling, and allergic asthma. New sphingolipid metabolites have been discovered as potential biomarkers of several lung diseases. Although multiple acute and chronic lung pathological conditions involve perturbations in sphingolipid signaling and metabolism, there are specific patterns, unique sphingolipid species, enzymes, metabolites, and receptors, which have emerged that deepen our understanding of lung pathophysiology and inform the development of new therapies for lung diseases.

5 January 2018 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
KMKenji Mizumura
Kenji Mizumura
MJMatthew J. Justice
Matthew J. Justice
KSKelly S. Schweitzer
Kelly S. Schweitzer
SKSheila Krishnan
Sheila Krishnan
IBIrina Bronova
Irina Bronova
IPIrina Petrache
Irina Petrache
The mechanisms by which lung structural cells survive toxic exposures to cigarette smoke (CS) are not well defined but may involve proper disposal of damaged mitochondria by macro‐autophagy (mitophagy), processes that may be influenced by pro‐apoptotic ceramide (Cer) or its precursor dihydroceramide (DHC). Human lung epithelial and endothelial cells exposed to CS exhibited mitochondrial damage, signaled by phosphatase and tensin homolog‐induced putative kinase 1 (PINK1) phosphorylation, autophagy, and necroptosis. Although cells responded to CS by rapid inhibition of DHC desaturase, which elevated DHC levels, palmitoyl (C16)‐Cer also increased in CS‐exposed cells. Whereas DHC augmentation triggered autophagy without cell death, the exogenous administration of C16‐Cer was sufficient to trigger necroptosis. Inhibition of Cer‐generating acid sphingomyelinase reduced both CS‐induced PINK1 phosphorylation and necroptosis. When exposed to CS, Pinkl‐deficient ( Pink1 −/− ) mice, which are protected from airspace enlargement compared with wild‐type littermates, had blunted C16‐Cer elevations and less lung necroptosis. CS‐exposed Pink1 −/− mice also exhibited significantly increased levels of lignoceroyl (C24)‐DHC, along with increased expression of Cer synthase 2 (CerS2 ), the enzyme responsible for its production. This suggested that a combination of high C24‐DHC and low C16‐Cer levels might protect against CS‐induced necroptosis. Indeed, CerS2 −/− mice, which lack C24‐DHC at the expense of increased C16‐Cer, were more susceptible to CS, developing airspace enlargement following only 1 month of exposure. These results implicate DHCs, in particular, C24‐DHC, as protective against CS toxicity by enhancing autophagy, whereas C16‐Cer accumulation contributes to mitochondrial damage and PINKl‐mediated necroptosis, which may be amplified by the inhibition of C24‐DHC‐producing CerS2 .— Mizumura, K., Justice, M.J., Schweitzer, K.S., Krishnan, S., Bronova, I., Berdyshev, E. V., Hubbard, W.C., Pewzner‐Jung, Y., Futerman, A. H., Choi, A. M. K., Petrache, I. Sphingolipid regulation of lung epithelial cell mitophagy and necroptosis during cigarette smoke exposure. FASEB J. 32, 1880–1890 (2018). www.fasebj.org

8 January 2021 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
KSKelly S. Schweitzer
Kelly S. Schweitzer
TCTaylor Crue
Taylor Crue
JNJordan M. Nall
Jordan M. Nall
DFDaniel Foster
Daniel Foster
SSSatria Sajuthi
Satria Sajuthi
IPIrina Petrache
Irina Petrache
Background: Patients with coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) demonstrate high rates of co-infection with respiratory viruses, including influenza A (IAV), suggesting pathogenic interactions.Methods: We investigated how IAV may increase the risk of COVID-19 lung disease, focusing on the receptor angiotensin-converting enzyme (ACE)2 and the protease TMPRSS2, which cooperate in the intracellular uptake of SARS-CoV-2.Results: We found, using single-cell RNA sequencing of distal human nondiseased lung homogenates, that at baseline, ACE2 is minimally expressed in basal, goblet, ciliated and secretory epithelial cells populating small airways. We focused on human small airway epithelial cells (SAECs), central to the pathogenesis of lung injury following viral infections. Primary SAECs from nondiseased donor lungs apically infected (at the air–liquid interface) with IAV (up to 3×105 pfu; ∼1 multiplicity of infection) markedly (eight-fold) boosted the expression of ACE2, paralleling that of STAT1, a transcription factor activated by viruses. IAV increased the apparent electrophoretic mobility of intracellular ACE2 and generated an ACE2 fragment (90 kDa) in apical secretions, suggesting cleavage of this receptor. In addition, IAV increased the expression of two proteases known to cleave ACE2, sheddase ADAM17 (TACE) and TMPRSS2 and increased the TMPRSS2 zymogen and its mature fragments, implicating proteolytic autoactivation.Conclusion: These results indicate that IAV amplifies the expression of molecules necessary for SARS-CoV-2 infection of the distal lung. Furthermore, post-translational changes in ACE2 by IAV may increase vulnerability to lung injury such as acute respiratory distress syndrome during viral co-infections. These findings support efforts in the prevention and treatment of influenza infections during the COVID-19 pandemic.